China’s 15th Five-Year Plan: Charting Solutions in an Uncertain World Media Outreach|27/03/202629/03/2026oleh RRINEWSS CGTN’s special feature explores potential impacts of China’s 15th Five-Year Plan beyond
Tech-Driven Restoration: Saving the World’s Critically Endangered White-headed Langur Media Outreach|27/03/202629/03/2026oleh RRINEWSS Through decades of careful conservation efforts, the white-headed langur population has increased
Ping An Digital Bank Embarks on a New Journey Media Outreach|26/03/2026oleh RRINEWSS “Always with You, Always Ahead,” From banking services to life protection planning,
Bridging the Digital Divide: 5G Drives Rural Revitalization in Guangxi, China Media Outreach|26/03/2026oleh RRINEWSS CHONGZUO, CHINA – Media OutReach Newswire – 26 March 2026 – In the karst
Ayako Rokkaku Unveils ‘THE ISLAND – ONIGASHIMA’ at LANDMARK: A Monumental Artistic Odyssey in Central Media Outreach|26/03/2026oleh RRINEWSS A Grand Scale Hong Kong Solo Debut Transforms the Atrium into a
Boao: Where the World Meets | Qionghai: Where Free Trade Thrives Media Outreach|26/03/2026oleh RRINEWSS Global Health Tech Debuts as Qionghai Leads the Wellness Wave QIONGHAI, CHINA
Zuellig Pharma Reinforces Commitment to Japan through Its New Misato Depot, Advancing Clinical Logistics and Sourcing Excellence Media Outreach|26/03/2026oleh RRINEWSS MISATO, JAPAN – Media OutReach Newswire – 26 March 2026 – Zuellig Pharma today
Contractor Confidence Rises Amid Strengthening Office Demand Across Asia Pacific Media Outreach|26/03/2026oleh RRINEWSS Contractor Sentiment Survey shows 70% of respondents expect improved market conditions in
Media OutReach Newswire Memperkuat Jangkauan Singapura and Asia Pasifik Lebih Lanjut dengan Kemitraan Strategis Bersama AsiaOne Media Outreach|25/03/2026oleh RRINEWSS Perjanjian bersama platform media digital Singapura memperkuat peran Media OutReach Newswire sebagai
Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes Media Outreach|25/03/2026oleh RRINEWSS UBT251 is a triple agonist of the receptors for GLP-1, GIP and
